Lillian M. Dampman, PhD
Senior Director, Strategic Delivery and Growth
- Over 35 years of experience in clinical research development with progressive positions in clinical operations starting as a CRA to leadership roles that led to NDA submissions
- Conducted medical and scientific reviews across multiple therapeutic indications to identify study risks and provide solutions for trial implementation
- Applies data-driven, analytic and innovative approaches in building the global clinical strategy and planning for Phases Ib-IV trials in renal therapeutic areas of various study designs and goals
- Broad therapeutic expertise including rare glomerular and non-glomerular diseases, acute and chronic conditions, in-patient or out-patient studies, and outcome trials
- Based in the United States